The Effects of Preeclampsia and Oxygen Environment on Endothelial Release of Matrix Metalloproteinase‐2

References

• Friedman S A, Taylor R N, Roberts J M. Pathophysiology of preeclampsia. Clin Perinatol 1991; 18(4)661–682, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer I A. Pre‐eclampsia: a multifaceted vascular disorder of pregnancy. J Hypertens 1994; 12(12)1339–1345, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Roberts J M, Redman C W. Pre‐eclampsia: more than pregnancy‐induced hypertension. Lancet 1993; 341(8858)1447–1451, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Roberts J M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16(1)5–15, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Rodgers G M, Taylor R N, Roberts J M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159(4)908–914, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hayman R, Brockelsby J, Kenny L, Baker P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig 1999; 6(1)3–10, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kenny L, Baker P N. Maternal pathophysiology in pre‐eclampsia. Baillieres Best Pract Res, Clin Obstet Gynaecol 1999; 13(1)59–75, [CROSSREF], [CSA]
   Google Scholar
• Taylor R N, Varma M, Teng N N, Roberts J M. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990; 71(6)1675–1677, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Taylor R N, Crombleholme W R, Friedman S A, Jones L A, Casal D C, Roberts J M. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 1991; 165(4 Pt 1)895–901, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Davidge S T, Signorella A P, Lykins D L, Gilmour C H, Roberts J M. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol 1996; 175(5)1301–1306, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Narumiya H, Zhang Y, Fernandez‐Patron C, Guilbert L J, Davidge S T. Matrix metalloproteinase‐2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 2001; 20(2)185–194, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell J, Docherty A. Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci 1994; 732: 31–41, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Springman E B, Angleton E L, Birkedal‐Hansen H, Van Wart H E. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active‐site zinc complex in latency and a “cysteine switch” mechanism for activation. Proc Natl Acad Sci U.S.A. 1990; 87(1)364–368, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fernandez‐Patron C, Radomski M W, Davidge S T. Vascular matrix metalloproteinase‐2 cleaves big endothelin‐1 yielding a novel vasoconstrictor. Circ Res 1999; 85(10)906–911
   PubMed Web of Science ®Google Scholar
• Fernandez‐Patron C, Stewart K G, Zhang Y, Koivunen E, Radomski M W, Davidge S T. Vascular matrix metalloproteinase‐2‐dependent cleavage of calcitonin gene‐related peptide promotes vasoconstriction. Circ Res 2000; 87(8)670–676
   PubMed Web of Science ®Google Scholar
• Himelstein B P, Koch C J. Studies of type IV collagenase regulation by hypoxia. Cancer Lett 1998; 124(2)127–133, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993; 53(4)288–295, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Pardo A, Barrios R, Maldonado V, Melendez J, Perez J, Ruiz V, Segura‐Valdez L, Sznajder J I, Selman M. Gelatinases A and B are up‐regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 1998; 153(3)833–844, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Hawkes S P, Li H, Taniguchi G T. Zymography and reverse zymography for detecting MMPs, and TIMPs. Methods Mol Biol 2001; 151: 399–410, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kleiner D E, Stetler‐Stevenson W G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994; 218(2)325–329, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. Activation of matrix metalloproteinases by peroxynitrite‐induced protein S‐glutathiolation via disulfide S‐oxide formation. J Biol Chem 2001; 276(31)29596–29602, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Maeda H, Okamoto T, Akaike T. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem 1998; 379(2)193–200, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Owens M W, Milligan S A, Jourd'heuil D, Grisham M B. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. Am J Physiol 1997; 273(2 Pt 1)L445–L450, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Overall C M, Wrana J L, Sodek J. Independent regulation of collagenase, 72‐kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor‐beta. J Biol Chem 1989; 264(3)1860–1869, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Heussen C, Dowdle E B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102(1)196–202, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Granelli‐Piperno A, Reich E. A study of proteases and protease‐inhibitor complexes in biological fluids. J Exp Med 1978; 148(1)223–234, [CROSSREF]
   Google Scholar
• Steinert J R, Wyatt A W, Poston L, Jacob R, Mann G E. Preeclampsia is associated with altered Ca2 + regulation and NO production in human fetal venous endothelial cells. FASEB J 2002; 16(7)721–723, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Wang Y, Gu Y, Granger D N, Roberts J M, Alexander J S. Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia. Am J Obstet Gynecol 2002; 186(2)214–220, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Dadak C, Ulrich W, Sinzinger H. Morphological changes in the umbilical arteries of babies born to pre‐eclamptic mothers: an ultrastructural study. Placenta 1984; 5(5)419–426, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Gilabert R, Bellart J, Jove M, Miralles R M, Piera V. Endothelial cell lesion in preeclampsia. Morphofunctional study using umbilical endothelial cells. Gynecol Obstet Investig 1999; 47(2)95–101, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• de Jager C A, Shephard E G, Robson S C, Jaskiewicz K, Froese S, Anthony J, Kirsch R E. Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia. J Lab Clin Med 1995; 125(4)522–530, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Bertrand C, Duperron L, St‐Louis J. Umbilical and placental vessels: modifications of their mechanical properties in preeclampsia. Am J Obstet Gynecol 1993; 168(5)1537–1546, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Remuzzi G, Marchesi D, Zoja C, Muratore D, Mecca G, Misiani R, Rossi E, Barbato M, Capetta P, Donati M B, de Gaetano G. Reduced umbilical and placental vascular prostacyclin in severe pre‐eclampsia. Prostaglandins 1980; 20(1)105–110, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Gallery E D, Campbell S, Arkell J, Nguyen M, Jackson C J. Preeclamptic decidual microvascular endothelial cells express lower levels of matrix metalloproteinase‐1 than normals. Microvasc Res 1999; 57(3)340–346, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Ben‐Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A. Regulation of endothelial matrix metalloproteinase‐2 by hypoxia/reoxygenation. Circ Res 2002; 90(7)784–791, [CROSSREF]
   Google Scholar
• Orphanides C, Fine L G, Norman J T. Hypoxia stimulates proximal tubular cell matrix production via a TGF‐beta1‐independent mechanism. Kidney Int 1997; 52(3)637–647, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Eddy A A. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7(12)2495–2508, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Canning M T, Postovit L M, Clarke S H, Graham C H. Oxygen‐mediated regulation of gelatinase and tissue inhibitor of metalloproteinases‐1 expression by invasive cells. Exp Cell Res 2001; 267(1)88–94, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Krtolica A, Ludlow J W. Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. Cancer Res 1996; 56(5)1168–1173, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sehgal I, Thompson T C. Novel regulation of type IV collagenase (matrix metalloproteinase‐9 and ‐2) activities by transforming growth factor‐beta1 in human prostate cancer cell lines. Mol Biol Cell 1999; 10(2)407–416, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Walton H L, Corjay M H, Mohamed S N, Mousa S A, Santomenna L D, Reilly T M. Hypoxia induces differential expression of the integrin receptors alpha(vbeta3) and alpha(vbeta5) in cultured human endothelial cells. J Cell Biochem 2000; 78(4)674–680, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Asahi H, Koshida K, Hori O, Ogawa S, Namiki M. Immunohistochemical detection of the 150‐kDa oxygen‐regulated protein in bladder cancer. BJU Int 2002; 90(4)462–466, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Baker P N, Krasnow J, Roberts J M, Yeo K T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995; 86(5)815–821, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Brockelsby J C, Anthony F, Wellings R, Baker P N. Increased circulating levels of vascular endothelial growth factor in preeclampsia. Hypertens Pregnancy 1998; 17(3)283–290
   Web of Science ®Google Scholar
• Sharkey A M, Cooper J C, Balmforth J R, McLaren J, Clark D E, Charnock‐Jones D S, Morris N H, Smith S K. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre‐eclampsia. Eur J Clin Investig 1996; 26(12)1182–1185, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Majka S, McGuire P G, Das A. Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Investig Ophthalmol Vis Sci 2002; 43(1)260–266, [CSA]
   Google Scholar
• Lamoreaux W J, Fitzgerald M E, Reiner A, Hasty K A, Charles S T. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 1998; 55(1)29–42, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Wang H, Keiser J A. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt‐1. Circ Res 1998; 83(8)832–840, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Dor Y, Herbert J M, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch C J, Ratcliffe P, Moons L, Jain R K, Collen D, Keshert E, Keshet E. Role of HIF‐1alpha in hypoxia‐mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394(6692)485–490, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Namiki A, Brogi E, Kearney M, Kim E A, Wu T, Couffinhal T, Varticovski L, Isner J M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995; 270(52)31189–31195, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wheeler T, Elcock C L, Anthony F W. Angiogenesis and the placental environment. Placenta 1995; 16(3)289–296, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Goldberg G I, Strongin A, Collier I E, Genrich L T, Marmer B L. Interaction of 92‐kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267(7)4583–4591, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Howard E W, Bullen E C, Banda M J. Regulation of the autoactivation of human 72‐kDa progelatinase by tissue inhibitor of metalloproteinases‐2. J Biol Chem 1991; 266(20)13064–13069, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Nguyen M, Arkell J, Jackson C J. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 2001; 33(10)960–970, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kazes I, Elalamy I, Sraer J D, Hatmi M, Nguyen G. Platelet release of trimolecular complex components MT1‐MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Blood 2000; 96(9)3064–3069, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar